Levisetti Matteo bought CUE
March 6, 2024 · Form 4 insider transaction
Levisetti Matteo bought 260,000 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
260,000
Price
$0.00
Total value
N/A
InsiderLevisetti Matteo
RoleOfficer
CompanyCue Biopharma, Inc. (CUE)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 6, 2024
Filing dateMarch 8, 2024
Shares owned after260,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024.